Item 5.02 Departure of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.



On January 11, 2022, Charles River Laboratories International, Inc. (the
"Company") announced that David R. Smith, its Corporate Executive Vice President
and Chief Financial Officer, will retire from the Company after a distinguished
career in healthcare and finance leadership roles. Mr. Smith will remain with
the Company in his current position until a successor has been named and the
transition has been completed, which is expected to occur before the end of
2022. Mr. Smith joined Charles River in 2014 through the Discovery Services
acquisition of Argenta and BioFocus. Following the acquisition, he assumed the
role of Corporate Vice President, Early Discovery Services, and was subsequently
named Corporate Senior Vice President, Global Discovery Services. In 2015,
leveraging Mr. Smith's extensive business, finance, and leadership experience,
the Company promoted Mr. Smith to his current role.

Item 7.01 Regulation FD Disclosure



The Company will be presenting at the 40th Annual J.P. Morgan Healthcare
Conference on January 11, 2022, at 10:30 a.m. Eastern time. Management of the
Company intends to present an overview of the Company's strategic focus,
business developments, and recent trends. Included in this overview will be
statements addressing the Company's perspective on its 2022 guidance and
financial outlook. In particular, in advance of the conference presentation, the
Company has posted a slide presentation on the Investor Relations section of its
website at http://ir.criver.com. This slide presentation includes the slides
attached hereto as Exhibit 99.1, which present statements as to the Company's
preliminary assessment of its 2022 guidance and financial outlook in the areas
of revenue growth, organic revenue growth, non-GAAP operating margin, non-GAAP
earnings per share, free cash flow, and capital expenditures.

The slide presentation attached hereto as Exhibit 99.1 includes "safe harbor"
language pursuant to the Private Securities Litigation Reform Act of 1995, as
amended, indicating that certain statements contained in the slide presentation
are "forward-looking," rather than historic. Forward-looking statements may be
identified by the use of words such as "anticipate," "believe," "expect,"
"intend," "will," "may," "estimate," "plan," "outlook," and "project" and other
similar expressions that predict or indicate future events or trends or that are
not statements of historical matters. Forward-looking statements are based on
the Company's current expectations and beliefs, and involve a number of risks
and uncertainties that are difficult to predict and that could cause actual
results to differ materially from those stated or implied by the forward-looking
statements. The slide presentation also states that these and other risks
relating to the Company are set forth in the documents filed by Charles River
with the Securities and Exchange Commission. The Company does not undertake to
update or revise its forward-looking statements or any of the information
contained in this Current Report on Form 8-K, including related to future events
or circumstances.

The information contained in this Item 7.01, including the exhibit furnished
hereto, is intended to be furnished and shall not be deemed "filed" for purposes
of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933 or the Securities Exchange Act of
1934, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description



             99.1         Charles River Laboratories International    ,

Inc.'s Slide Presentation for


                        the     40th Annual     J.P. Morgan     Healthcare

Conference slide presentation,


                        dated January 11, 2022
              104       Cover Page Interactive Data File (embedded within

the Inline XBRL document)


                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses